X

Caplin Point Laboratories Ltd Q1FY24; 21% rise in Profits

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.

Financial Results:

Caplin Point Laboratories Ltd reported Revenues for Q1FY24 of ₹395.00 Crores up from ₹346.00 Crore year on year, a rise of 14.16%.

Total Expenses for Q1FY24 of ₹280.00 Crores up from ₹255.00 Crores year on year, a rise of 9.8%.

Consolidated Net Profit of ₹104.00 Crores up 20.93% from ₹86.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹13.62, up 21.50% from ₹11.21 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post